Literature DB >> 6362275

Hemagglutinins of Klebsiella pneumoniae and Klebsiella oxytoca.

A Przondo Hessek, G Pulverer.   

Abstract

The occurrence and characteristics of hemagglutinins were investigated in 310 Klebsiella strains (195 K. pneumoniae- and 115 K. oxytoca-strains). Mannose-sensitive (MS)-hemagglutinins as well as Mannose-resistant (MR/K)-hemagglutinins could be demonstrated, only 13 Klebsiella-strains were not able to hemagglutinate. MS-hemagglutinins were much more often found in K. pneumoniae- than in K. oxytoca-strains, whereas the MR/K-hemagglutinin-frequency was equally high. Features (resistance to formaldehyde, trypsin, pronase, glycosidases, sodium metaperiodate and heating) and pathogenic significance of these hemagglutinins (fimbriae) were discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6362275

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  5 in total

1.  Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract.

Authors:  T A Oelschlaeger; B D Tall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Type 3 fimbriae among enterobacteria and the ability of spermidine to inhibit MR/K hemagglutination.

Authors:  G F Gerlach; B L Allen; S Clegg
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

3.  R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections.

Authors:  A Darfeuille-Michaud; C Jallat; D Aubel; D Sirot; C Rich; J Sirot; B Joly
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 4.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

5.  Adherence to respiratory epithelia by recombinant Escherichia coli expressing Klebsiella pneumoniae type 3 fimbrial gene products.

Authors:  D B Hornick; B L Allen; M A Horn; S Clegg
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.